Studies
-
Status: Implementation
TB- PRACTECAL: A randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug resistant tuberculosis.
Principal investigator: Bern-Thomas Nyang'waLatest update: Document added | 19th March 2024Impact: External Policy added by Bern-thomas nyang'wa | 15th Nov 2016